Staff Data Search - جامعة الزقازيق

Academic Jobs

معيد : 9/4/2020
Doctor Assisant : 29/6/2022
Doctor : 31/12/2024

Publications

1 - Synthesis and in vitro study of pyrimidine–phthalimide hybrids as VEGFR2 inhibitors with antiproliferative activity (2023).

2 - Synthesis and molecular docking of some novel 3-thiazolyl-coumarins as inhibitors of VEGFR-2 kinase (2023).

3 - Mechanochemical synthesis and molecular docking studies of new azines bearing indole as anticancer agents (2023).

4 - Green synthesis and molecular docking study of some new thiazoles using terephthalohydrazide chitosan hydrogel as ecofriendly biopolymeric catalyst (2023).

5 - Green route synthesis and molecular docking of azines using cellulose sulfuric acid under microwave irradiation (2023).

6 - Synthesis, molecular docking study, and biological evaluation and of new thiadiazole and thiazole derivatives incorporating isoindoline-1,3-dione moiety as anticancer and antimicrobial agents (2024).

7 - Green Biocatalyst for Ultrasound-Assisted Thiazole Derivatives: Synthesis, Antibacterial Evaluation, and Docking Analysis (2024).

8 - Cyanauric Chloride as a key precursor and a core component for Three-Armed Triazolopyrimidines: Recent finding about SARs and docking analyses (2024).

9 - Chitosan–sulfonic acid-catalyzed green synthesis of naphthalene-based azines as potential anticancer agents (2024).

10 - Synthesis, molecular docking, in silico study, and evaluation of bis-thiazole-based curcumin derivatives as potential antimicrobial agents (2024).

11 - Design and synthesis of novel hybrids incorporating thiadiazole or thiazole-naphthalene: Anticancer assessment and molecular docking study (2024).

12 - Design, synthesis and antitumor activity of novel pyran-functionalized uracil derivatives: docking studies (2023).

13 - Green synthesis of hydrazono-thiazolones using vitamin B1 and their antibacterial implications (2024).

14 - Efficient Green Synthesis of Hydrazide Derivatives Using L-Proline: Structural Characterization, Anticancer Activity, and Molecular Docking Studies (2024).

15 - Facile one-pot synthesis and in silico study of new heterocyclic scaffolds with 4-pyridyl moiety: Mechanistic insights and X-ray crystallographic elucidation (2024).

16 - Synthesis of novel Bis-1, 2, 4-Triazolo [3, 4-b][1, 3, 4] Thiadiazines from natural camphoric acid as potential anti-candidal agents (2024).

17 - Synthesis of Bis-thiazoles Tethered 1,4-Dihydropyridine and Pyridine Linkers via Simple Oxidation and their Molecular Docking as VEGFR -TK Inhibitors (2024).

18 - Novel phthalimide-pyrimidine hybrids as potent anti-tubercular agents (2024).

19 - Corrigendum to “Synthesis, molecular docking study, and biological evaluation and of new thiadiazole and thiazole derivatives incorporating isoindoline-1, 3-dione moiety as … (2024).

20 - Novel thiazolyl-pyrimidine derivatives as potential anticancer agents: Synthesis, biological evaluation, and molecular docking studies (2024).

21 - Synthesis, Molecular Docking and Anticancer Activity of Some 5-Aryl-5,10-dihydropyrido[2,3-d:6,5-d′]dipyrimidine-2,4,6,8-tetraone Derivatives and Pyrido[2,3-d]pyrimidines (2022).

22 - Synthesis, characterization, and in silico studies of substituted 2,3-dihydro-1,3,4-thiadiazole derivatives (2024).

23 - Synthesis of Bis-Pyrimidothiazine and Bis-Pyrimidothiadiazinone derivatives as VEGFR2/KDR inhibitors via Michael and Mannich reactions (2025).

24 - Biological evaluation and molecular docking studies of novel aza-acyclic nucleosides as putative antimicrobial, anticancer, and antioxidant agents (2025).

25 - Using terephthalohydrazide chitosan hydrogel as ecofriendly biopolymeric catalyst (2023).

26 - Synthesis, Anticancer Evaluation, and Molecular Docking of Novel Thiazolobenzimidazole–Thiazole Hybrids as Potent Colon Cancer Inhibitors (2025).

27 - Antiplatelet therapy through inhibition of P2Y12 and phosphodiesterase receptors by novel synthesis 1,3-dicyclohexylpyrimidine-2,4(1H,3H)-dione derivatives with computational evaluation (2025).

28 - Design and Evaluation of Novel Benzimidazolo-Triazole-Tetrazole Derivatives as Anticancer Agents Against MCF-7 Cells (2025).

29 - Novel pyrimidinone scaffolds synthesized via nanotechnology as promising inhibitors of the hepatitis A virus with computational analyses (2025).

30 - Benzimidazotriazines as adenosine receptor-targeting anticancer agents: Synthesis, cytotoxicity, DFT, and docking studies (2025).

31 - Design, Synthesis, Cytotoxicity Assessment, and Molecular Docking of Novel Triazolopyrimidines as Potent Cyclin-Dependent Kinase 4 Inhibitors (2025).

32 - Synthesis of Pyrido[2,3-d]Azolopyrimidinones: Design and Epidermal Growth Factor Receptor-Targeted Molecular Docking Toward Novel Anticancer Leads (2025).

33 - Design, Synthesis, and Biological Assessment of Bis-thiazole Derivatives as Promising Anticancer Agents with Molecular Docking Insights (2025).

34 - A Novel Series of Benzimidazole-Triazole-Tetrazole Compounds: Synthesis, Structural Analysis, and Cytotoxic Activity Against MCF-7 Cells (2025).

35 - Innovative Pivaloyl Fixed 1,3-Thiazole-2-imines as Multitarget Inhibitors: Synthesis, Enzyme Inhibition, Molecular Docking and Structure Activity Relationship (SAR) Studies (2025).

36 - Novel pyrimidine derivatives: Synthesis, Molecular Docking Studies, and structure activity relationship (2023).

37 - Benzimidazole chemistry in oncology: recent developments in synthesis, activity, and SAR analysis (2025).

38 - Synthesis of Bis-thiazoles Tethered 1,4-Dihydropyridine and Pyridine Linkers via Simple Oxidation and their Molecular Docking as VEGFR-TK Inhibitors (2024).

39 - Ascorbic acid exhibits more of a protective effect than estradiol against nephrotoxicity induced by malathion in rats: a histopathological and molecular docking study (2025).

40 - Novel bis-Thiazolidinone -based chalcones with pyridine linker: Eco-friendly synthesis, cholinesterase and beta-amyloid inhibition potency, and molecular docking studies (2025).

41 - Synthesis and Biological Evaluation of Thiazolyl–Pyrimidine Hybrids as Potential Antiproliferative Agents with Molecular Docking Insights (2025).

42 - Synthesis, docking, SAR and ADMET evaluation of novel pyrrolo[3,4-c]pyrazole-4,6-dione derivatives (2026).

43 - Novel guanidine derivatives as mechanistic scaffolds for anticancer agents: synthesis, characterization, DNA-binding, and computational studies (2025).

44 - Synthesis, in silico and in vitro studies of aminopyrimidine hybrids as EGFR TK inhibitors and anti-proliferative agents (2025).

45 - Multimodal investigation of a fluorinated isocoumarin scaffold: Synthesis, crystal structure, and anticancer targeting via DFT, docking, and ADMET profiling (2026).

46 - Synthesis, in silico and in vitro studies of aminopyrimidine hybrids as EGFR TK inhibitors and anti-proliferative agents (2025).

47 - Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents (2025).

48 - Integrated experimental and computational evidence for Cymbopogon citratus as an anti-SARS-CoV-2 agent (2026).

49 - Solvent-free synthesis of quinazolinone–chalcone hybrids and their evaluation as dual inhibitors of AChE and BuChE for alzheimer’s disease. (2026).

50 - Factors affecting pesticide degradation in agricultural soil (2026).

51 - Mechanisms and pathways of pesticide degradation (2026).

52 - Identification of Bioactive Compounds in Cordia myxa L. Extract for Extending the Refrigerated Shelf Life of beef (2026).

53 - Design, Synthesis, and Biological Evaluation of Novel Quinazoline–Thiazole Hybrids as Potential Anticancer Agents (2026).

54 - Green NiO nanoparticle catalyzed synthesis of novel triazolopyrimidine derivatives with physicochemical characterization and computational evaluation for gout therapy (2026).

55 - Proficient pyrimidine-based heterocyclic chemistry in medicine: advances in synthesis, biological, and SAR studies: a review (2026).

Research Area

Scientific degrees